Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation
Sick Sinus Syndrome
About this trial
This is an interventional prevention trial for Sick Sinus Syndrome focused on measuring Cardiac Pacing, artificial, Atrial fibrillation, Pacemaker leads, Lead positions
Eligibility Criteria
Inclusion Criteria: Sick Sinus Syndrome Symptomatic sinus bradycardia Symptomatic SA block Bradycardia-Tachycardia-Syndrom Binodal diseases, Sinus Node Syndrome and high degree AV-Block In case of antiarrhythmic drug therapy: patient must be on a stable dose for at least 3 months before enrollment Exclusion Criteria: Permanent atrial tachycardia that cannot be transferred into sinus rhythm by drugs or electric cardioversion Decompensated heart failure Dilatative cardiomyopathy with an ejection fraction < 35% Hypertrophic obstructive cardiomyopathy Symptomatic hypo- or hyperthyreosis Myocardial infarction less than 6 months ago Planned cardiac surgery intervention Pregnant woman Patients under 18 years of age Patients involved in other studies Patients, already implanted with other (cardiac) leads Patients with reduced expectancy of life due to other diseases Patients who are not able to agree in participation of the study Patients, who cannot attend follow-up visits due to their place of residence
Sites / Locations
- Helios-Klinikum Aue
- Klinikum Coburg
- Ambulantes Herz-Zentrum Dresden
- Werner-Forssmann-Krankenhaus GmbH
- Klinikum der Joh.-Wolfgang-Goethe-Universität
- Städtisches Krankenhaus Friedrichshafen
- Universitätskrankenhaus Eppendorf
- Evang. Krankenhaus
- Klinikum Ingolstadt
- Evangelisches Krankenhaus Kalk GmbH
- Kreiskrankenhaus Leer
- Krankenhaus Maria Hilf